Company
Company

Technology powers us. Drug development defines us.

Technology powers us. Drug development defines us.

Novorex is a drug development company integrating AI, FBDD, and biophysical validation to identify real binders and advance high-unmet-need CNS and inflammation pipelines.

Novorex is a drug development company integrating AI, FBDD, and biophysical validation to identify real binders and advance high-unmet-need CNS and inflammation pipelines.

03 / Scientific Advisory Board
Scientific Advisory Board

Distinguished advisors provide scientific, clinical, translational, and intellectual property guidance across Novorex's discovery and development programs.

03 / 05
Scientific Advisory Board

Han Seok Ko, Ph.D.

Professor of Neurology, Institute for Cell Engineering
Johns Hopkins University School of Medicine

Dr. Han Seok Ko is a Professor of Neurology and faculty member of the Institute for Cell Engineering at Johns Hopkins University School of Medicine. He is an internationally recognized neuroscientist focused on Parkinson's disease and related neurodegenerative disorders, with expertise in alpha-synuclein pathology, neuroinflammation, lysosomal dysfunction, and therapeutic target discovery.

Parkinson'sNeuroinflam.Alpha-SynucleinTargets
Scientific Advisory Board

Jae Gook Shin, M.D., Ph.D.

Professor, Pharmacology & Clinical Pharmacology, Inje University
Chief Executive Officer, SPMED Co., Ltd.

Dr. Jae Gook Shin is a leading clinical pharmacologist in Korea with extensive expertise in pharmacogenomics, personalized medicine, clinical PK/PD, drug metabolism, drug-drug interactions, clinical trials, and new drug development.

Clinical Pharm.Pharmacogen.PK/PDClinical Trials
Scientific Advisory Board

Dong Hyun Kim, Ph.D.

Chief Technology Officer, SPMED Co., Ltd.
Professor Emeritus, College of Medicine, Inje University

Dr. Dong Hyun Kim is Chief Technology Officer at SPMED and Professor Emeritus at Inje University College of Medicine. He is an internationally recognized expert in ADME/DMPK, with extensive experience in drug metabolism, bioanalysis, pharmacokinetics, metabolomics, and drug-drug interaction assessment.

ADME/DMPKMetabolismBioanalysisPK
Scientific Advisory Board

Eun Sun Choi, Pharm. / Patent Atty.

Chief Managing Partner, Choi & Partners
Patent Attorney / Pharmacist

Ms. Eun Sun Choi is Chief Managing Partner of Choi & Partners and a pharmacist and patent attorney with deep expertise in pharmaceutical and biotechnology intellectual property strategy, patent prosecution, IP portfolio strategy, patent litigation support, and freedom-to-operate counseling.

Pharma IPPatent Strat.FTOBiotech IP